Venture Philanthropy in Action: A Case Study of EB Research Partnership and ProQR

Venture Philanthropy in Action: A Case Study of EB Research Partnership and ProQR

Share

Details

How are nonprofit organizations leveraging venture philanthropy to accelerate the development of treatments and cures? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures takes a deeper dive into the venture philanthropy approach of EB Research Partnership, the largest global nonprofit organization dedicated to treating and curing Epidermolysis Bullosa (EB). To date, EB Research Partnership has funded 80 research projects, which has led to 30 clinical trials, including 3 Phase III trials.

Moderator

Kristin Schneeman, Program Director, FasterCures

Panel Experts and Speakers

Michael Hund, CEO of EB Research Partnership

Alex Silver, Chairman of EB Research Partnership

Daniel de Boer, CEO of ProQR Therapeutics

Mark de Souza, CEO of Wings Therapeutics

For more information about the conference call, click here.

Tags
Topics
Tags
Topics
Published August 17, 2020